Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury

Tissue Engineering - Part A

Volumn 16, Issue 11, 2010, Pages 3329-3341

  Matsushima, Kentaro ^a,b   Suyama, Takashi ^a,b   Takenaka, Chiemi ^a,c   Nishishita, Naoki ^a,c   Ikeda, Keiko ^d   Ikada, Yoshito ^e   Sawa, Yoshiki ^f   Jakt, Lars Martin ^c   Mori, Hajime ^d,g   Kawamata, Shin ^a,c  

^a FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b Bay Bioscience Corp   (Japan)

^c Center for Developmental Biology   (Japan)

^d Protein Crystal Corporation   (Japan)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; PHOSPHORYLATION;

CANONICAL WNT SIGNALING; CARDIAC FUNCTIONS; CARDIAC WALL; IMMUNOHISTOLOGY; IN-CONTROL; INTRAMUSCULAR ADMINISTRATION; ISCHEMIC INJURIES; RAT HEART; RECANALIZATION; SLOW RELEASE;

HEART;

RATTUS;

BETA CATENIN; BIOMATERIAL; CARDIOTONIC AGENT; ONCOPROTEIN; RECOMBINANT PROTEIN; SFRP4 PROTEIN, HUMAN; SFRP4 PROTEIN, MOUSE; WNT PROTEIN;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; FIBROSIS; GENETIC TRANSCRIPTION; GENETICS; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BETA CATENIN; BIOCOMPATIBLE MATERIALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FIBROSIS; HEART FUNCTION TESTS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MYOCARDIAL ISCHEMIA; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION; WNT PROTEINS;

EID: 78149250947     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0739     Document Type: Article

References (38)

1. Meyer, G.P., Wollert, K.C., Lotz, J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration). Circ Trial 113, 1287, 2006.
2. Janssens, S., Dubois, C., Bogaert, J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-seg-ment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113, 2006.
3. Lunde, K., Solheim, S., Aakhus, S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myo-cardial infarction. N Engl J Med 355, 1199, 2006.
4. Menasche, P., Alfieri, O., Janssens, S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189, 2008.
5. Zhang, F., and Pasumarthi, K.B. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs 22, 361, 2008.
6. Zhu, W.Z., Hauch, K.D., Xu, C., et al. Human embryonic stem cells and cardiac repair. Transplant Rev 23, 53, 2009.
7. QGenomics of Cardiovascular Development, Adaptation, and Remodeling. NHLBI Program for Genomic Applications. Harvard Medical School. Available at www.cardio genomics.org, accessed February 2004.
8. Hata, H., Matsumiya, G., Miyagawa, S., et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardi-ovasc Surg 132, 918, 2006.
9. Fukui, S., Kitagawa-Sakakida, S., Kawamata, S., et al. Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts. Ann Thorac Surg 85, 562, 2008.
10. Tendeng, C., and Houart, C. Cloning and embryonic expression of five distinct sfrp genes in the zebrafish Danio rerio. Expr Patterns 6, 761, 2006.
11. Bovolenta, P., Esteve, P., Ruiz, J.M., Cisneros, E., and Lopez-Rios, J. Beyond Wnt inhibition: new functions of secreted frizzled-related proteins in development and disease. J Cell Sci 121, 737, 2008.
12. Hoang, B.H., Thomas, J.T., Abdul-Karim, F.W., Correia, K.M., Conlon, R.A., Luyten, F.P., and Ballock, R.T. Expression pattern of two frizzled-related genes, Frzb-1 and Sfrp-1, during mouse embryogenesis suggests a role for modulating action of Wnt family members. Dev Dyn 212, 364, 1998.
13. Jones, S.E., and Jomary, C. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 24, 811, 2002.
14. Leimeister, C., Bach, A., and Gessler, M. Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. Gene Mech Dev 75, 29, 1998.
15. Kemp, C., Willems, E., Abdo, S., Lambiv, L., and Leyns, L. Expression of all Wnt genes and their secreted antagonists during mouse blastocyst and postimplantation development. Dev Dyn 233, 1064, 2005.
16. Kawano, Y., and Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116, 2627, 2003.
17. Rattner, A., Hsieh, J.C., Smallwood, P.M., Gilbert, D.J., Copeland, N.G., Jenkins, N.A., and Nathans, J. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. PNAS 94, 2859, 1997.
18. Uren, A., Reichsman, F., Anest, V., Taylor, W.G., Muraiso, K., Bottaro, D.P., Cumberledge, S., and Rubin, J.S. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275, 4374, 2000.
19. Hayashida, K., Sano, M., Ohsawa, I., Shinmura, K., Tamaki, K., Kimura, K., Endo, J., Katayama, T., Kawamura, A., Kohsaka, S., Makino, S., Ohta, S., Ogawa, S., and Fukuda, K. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 373, 30, 2008.
20. Cheon, S., Poon, R., Yu, C., et al. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab Invest 85, 416, 2005.
21. Coulibaly, F., Chiu, E., Ikeda, K., et al. The molecular organization of cypovirus polyhedra. Nature 446, 97, 2007.
22. Ikeda, K., Nakazawa, H., Shimo-Oka, A., Ishio, K., Miyata, S., Hosokawa, Y., Matsumura, S., Masuhara, H., Belloncik, S., Alain, R., Goshima, N., Nomura, N., Morigaki, K., Kawai, A., Kuroita, T., Kawakami, B., Endo, Y., and Mori, H. Immobilization of diverse foreign proteins in viral polyhedra and potential application for protein microarrays. Pro-teomics 6, 54, 2006.
23. Mori, H., Shukunami, C., Furuyama, A., et al. Immobilization of bioactive fibroblast growth factor-2 into cubic pro-teinous microcrystals (Bombyx mori cypovirus polyhedra) that are insoluble in a physiological cellular environment. J Biol Chem 282, 17289, 2007.
24. Suzuki, S., Matsuda, K., Isshiki, N., Tamada, Y., Yoshioka, K., and Ikada, Y. Clinical evaluation of a new bilayer "artificial skin" composed of collagen sponge and silicone layer. Br J Plast Surg 43, 47, 1990.
25. Nordentoft, T., Romer, J., and Sorensen, M. Sealing of gastrointestinal anastomoses with a fibrin glue-coated collagen patch: a safety study. J Invest Surg 20, 363, 2007.
26. Gavert, N., and Ben-Ze'ev, A. Beta-catenin signaling in biological control and cancer. J Cell Biochem 102, 820, 2007.
27. Xu, W., and Kimelman, D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci 120, 3337, 2007.
28. Kanda, S., Miyata, Y., and Kanetake, H. T-cell factor-4-de-pendent up-regulation of fibronectin is involved in fibroblast growth factor-2-induced tube formation by endothelial cells. J Cell Biochem 94, 835, 2005.
29. Barandon, L., Dufourcq, P., Costet, P., et al. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ Res 96, 1299, 2005.
30. Kobayashi, K., Luo, M., Zhang, Y., et al. Secreted frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11, 46, 2009.
31. Suzuki, H., Watkins, D.N., Jair, K.W., et al. Epigenetic inac-tivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36, 417, 2004.
32. Zeisberg, E.M., Tarnavski, O., Zeisberg, M., et al. En-dothelial-to- mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952, 2007.
33. Jacob, R., Dierberger, B., and Kissling, G. Functional significance of the Frank-Starling mechanism under physiological and pathophysiological conditions. Eur Heart J 13 Suppl E, 7, 1992.
34. Rosenkranz, S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63, 423, 2004.
35. Bayle, J., Fitch, J., Jacobsen, K., et al. Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis. J Invest Dermatol 128, 871, 2008.
36. Surendran, K., Schiavi, S., and Hruska, K.A. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Ne-phrol 16, 2373, 2005.
37. Varallo, V.M., Gan, B.S., Seney, S., Ross, D.C., et al. Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 22, 3680, 2003.
38. Bowley, E., O'Gorman, D.B., and Gan, B.S. Beta-catenin signaling in fibroproliferative disease. J Surg Res 138, 141, 2007.